Evidence map›Paper›PMID 28833674›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2017

C-H Cyanation of 6-Ring N-Containing Heteroaromatics.

Bryony L Elbert, Alistair J M Farley, Timothy W Gorman, Tarn C Johnson, Christophe Genicot, Bénédicte Lallemand, Patrick Pasau, Jakub Flasz, José L Castro, Malcolm MacCoss and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 41 citations in OpenAlex.

  1. Formal Synthesis ofMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Direct Regioselective C-H Cyanation of Purines.Molecules (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. C-H Cyanation of 6-Ring N-Containing Heteroaromatics.Chemistry (Weinheim an der Bergstrasse, Germany) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Bryony L ElbertDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
Alistair J M FarleyDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
Timothy W GormanDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
Tarn C JohnsonDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
Christophe GenicotGlobal Chemistry, UCB New Medicines, UCB Biopharma sprl, 1420, Braine-L'Alleud, Belgium.
Bénédicte LallemandGlobal Chemistry, UCB New Medicines, UCB Biopharma sprl, 1420, Braine-L'Alleud, Belgium.
Patrick PasauGlobal Chemistry, UCB New Medicines, UCB Biopharma sprl, 1420, Braine-L'Alleud, Belgium.
Jakub FlaszGlobal Chemistry, UCB, 216 Bath Road, Slough, SL1 3WE, UK.
José L CastroGlobal Chemistry, UCB, 216 Bath Road, Slough, SL1 3WE, UK.
Malcolm MacCossBohicket Pharma Consulting LLC, 2556 Seabrook Island Road, Seabrook Island, South Carolina, 29455, USA.
Robert S PatonDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
Christopher J SchofieldDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
Martin D SmithDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
Michael C WillisDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.ORCID http://orcid.org/0000-0002-0636-6471
Darren J DixonDepartment of Chemistry, Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.ORCID http://orcid.org/0000-0003-2456-5236
University of Oxford · GBUCB Pharma (Belgium) · BEUCB Pharma (United Kingdom) · GBSeabrook · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Heteroaromatic nitriles are important compounds in drug discovery, both for their prevalence in the clinic and due to the diverse range of transformations they can undergo. As such, efficient and reliable methods to access them have the potential for far-reaching impact across synthetic chemistry and the biomedical sciences. Herein, we report an approach to heteroaromatic C-H cyanation through triflic anhydride activation, nucleophilic addition of cyanide, followed by elimination of trifluoromethanesulfinate to regenerate the cyanated heteroaromatic ring. This one-pot protocol is simple to perform, is applicable to a broad range of decorated 6-ring N-containing heterocycles, and has been shown to be suitable for late-stage functionalization of complex drug-like architectures.

Indexed as

cyanationheterocycleslate-stage functionalizationnitriles

Identifiers

PMID28833674
PMCPMC5813275
OpenAlexW2748707905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.